Journal of Biological Chemistry· 2026Q1
Distinct proteomic and acylproteomic adaptations to succinate dehydrogenase loss in two cell contexts
- 1citations
- Q1SCImago
- 2026year
Short summary
Succinate dehydrogenase (SDH) loss uniquely upregulates mitochondrial proteins and fatty acid oxidation (FAO) in mouse chromaffin cells (imCCs), but not fibroblasts (iMEFs), revealing cell-type specific metabolic adaptations.
AI-generated from the title and abstract; the full text is not read.
Key points
- SDH-loss imCCs show significant upregulation of mitochondrial proteins and downregulation of nuclear proteins, unlike iMEFs.
- Fatty acid β-oxidation (FAO) activity is uniquely increased in SDH-loss imCCs, but not iMEFs.
- SDH loss causes disproportionate hyperacetylation in both cell types, but imCCs uniquely show hypoacetylation of mitochondrial proteins.
- SDH loss leads to mixed succinylation patterns, with imCCs showing hyposuccinylation of mitochondrial proteins.
AI-generated from the title and abstract; the full text is not read.
Abstract
Background: The tricarboxylic acid (TCA) cycle and electron transport chain (ETC) are key metabolic pathways required for cellular ATP production. While loss of components in these pathways typically impairs cell survival, such defects can paradoxically promote tumorigenesis in certain cell types. One such example is loss of succinate dehydrogenase (SDH), which functions in both the TCA cycle and as Complex II of the ETC. Deleterious mutations in SDH subunits can cause pheochromocytoma and paraganglioma (PPGL), rare hereditary neuroendocrine tumors of chromaffin cells in the adrenal gland and the nerve ganglia, respectively. Why tumor formation upon SDH loss is limited to certain tissues remains unclear. We hypothesized that the metabolic and proteomic perturbations resulting from SDH loss are cell-type specific, favoring survival of chromaffin cells. Methods: We comprehensively examined the proteomic, acetylproteomic, and succinylproteomic effects of SDH loss in two cell models, immortalized mouse chromaffin cells (imCCs) and immortalized mouse embryonic fibroblasts (iMEFs). Perturbations in metabolite levels were determined by mass spectrometry. Effects of SDH loss on fatty acid β-oxidation (FAO) were assessed by stable isotope tracing and pharmacologic inhibition. Results: SDH-loss imCCs show significant upregulation of mitochondrial proteins, including TCA cycle and FAO enzymes, with pronounced downregulation of nuclear proteins. Both imCCs and iMEFs demonstrate significant energy deficiency upon SDH loss, but FAO activity is uniquely increased in SDH-loss imCCs. While SDH loss increases both lysine-reactive acetyl-CoA and succinyl-CoA, SDH-loss imCCs and iMEFs show disproportionate hyperacetylation but mixed succinylation. Surprisingly, SDH-loss imCCs, but not iMEFs, display disproportionate hypoacetylation and hyposuccinylation of mitochondrial proteins. Conclusions: SDH loss differentially impacts the proteomes and acylproteomes of imCCs and iMEFs, with compartment-specific effects. These findings reveal cell type-specific adaptations to SDH loss. The plasticity of the response of imCCs may underlie the tissue-specific susceptibility to tumorigenesis and could illuminate therapeutic vulnerabilities of SDH-loss tumors.
The authors' abstract, as published at the source. Journal of Biological Chemistry, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Cancer ResearchBiochemistry, Genetics and Molecular Biology